Top compounds associated with response to GTF2E1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA neratinib CTRPv2 pan-cancer AAC -0.082 0.02
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC 0.16 0.02
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.074 0.02
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.078 0.02
mRNA thalidomide CTRPv2 pan-cancer AAC -0.12 0.02
mRNA leptomycin B CTRPv2 pan-cancer AAC 0.077 0.02
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.02
mRNA B02 CTRPv2 pan-cancer AAC 0.082 0.02
Download CSV